Legorreta Pablo G. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Legorreta Pablo G.（CIK 1507678）在 2 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-08-07）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-07 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | 买入 | 65,216 | $0 |
| 2026-05-08 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | 买入 | 143,821 | $0 |
| 2026-02-13 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | 买入 | 157,828 | $0 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | 买入 | 36,559 | $0 |
| 2025-08-08 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | 买入 | 21,901 | $0 |
| 2025-06-05 | PROKIDNEY CORP. (PROK) | 董事 | 买入 | 3.8M | $0 |
| 2025-06-05 | PROKIDNEY CORP. (PROK) | 董事 | 卖出 | 3.8M | $0 |
| 2025-05-20 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | 买入 | 530,348 | $0 |
| 2025-05-09 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | 买入 | 288,352 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-07